Literature DB >> 21497800

TLR4-dependent activation of inflammatory cytokine response in macrophages by Francisella elongation factor Tu.

Jyotika Sharma1, Bibhuti B Mishra, Qun Li, Judy M Teale.   

Abstract

The bacterial determinants of pulmonary Francisella induced inflammatory responses and their interaction with host components are not clearly defined. In this study, proteomic and immunoblot analyses showed presence of a cytoplasmic protein elongation factor Tu (EF-Tu) in the membrane fractions of virulent Francisella novicida, LVS and SchuS4, but not in an attenuated F. novicida mutant. EF-Tu was immunodominant in mice vaccinated and protected from virulent F. novicida. Moreover, recombinant EF-Tu induced macrophages to produce inflammatory cytokines in a TLR4 dependent manner. This study shows immune stimulatory properties of a cytoplasmic protein EF-Tu expressed on the membrane of virulent Francisella strains.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21497800      PMCID: PMC3106127          DOI: 10.1016/j.cellimm.2011.03.023

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  22 in total

1.  Identification of novel antigenic proteins in a complex Anaplasma marginale outer membrane immunogen by mass spectrometry and genomic mapping.

Authors:  Job E Lopez; William F Siems; Guy H Palmer; Kelly A Brayton; Travis C McGuire; Junzo Norimine; Wendy C Brown
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

2.  A comprehensive transposon mutant library of Francisella novicida, a bioweapon surrogate.

Authors:  Larry A Gallagher; Elizabeth Ramage; Michael A Jacobs; Rajinder Kaul; Mitchell Brittnacher; Colin Manoil
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-10       Impact factor: 11.205

3.  Long lived protection against pneumonic tularemia is correlated with cellular immunity in peripheral, not pulmonary, organs.

Authors:  Rebecca V Anderson; Deborah D Crane; Catharine M Bosio
Journal:  Vaccine       Date:  2010-08-03       Impact factor: 3.641

4.  Perception of the bacterial PAMP EF-Tu by the receptor EFR restricts Agrobacterium-mediated transformation.

Authors:  Cyril Zipfel; Gernot Kunze; Delphine Chinchilla; Anne Caniard; Jonathan D G Jones; Thomas Boller; Georg Felix
Journal:  Cell       Date:  2006-05-19       Impact factor: 41.582

Review 5.  Tularemia as a biological weapon: medical and public health management.

Authors:  D T Dennis; T V Inglesby; D A Henderson; J G Bartlett; M S Ascher; E Eitzen; A D Fine; A M Friedlander; J Hauer; M Layton; S R Lillibridge; J E McDade; M T Osterholm; T O'Toole; G Parker; T M Perl; P K Russell; K Tonat
Journal:  JAMA       Date:  2001-06-06       Impact factor: 56.272

6.  Profiling of human antibody responses to Chlamydia trachomatis urogenital tract infection using microplates arrayed with 156 chlamydial fusion proteins.

Authors:  Jyotika Sharma; Youmin Zhong; Feng Dong; Jeanna M Piper; Guqi Wang; Guangming Zhong
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

7.  A general role for surface membrane proteins in attachment to chitin particles and copepods of environmental and clinical vibrios.

Authors:  L Vezzulli; E Pezzati; B Repetto; M Stauder; G Giusto; C Pruzzo
Journal:  Lett Appl Microbiol       Date:  2007-10-16       Impact factor: 2.858

8.  Immune evasion of the human pathogen Pseudomonas aeruginosa: elongation factor Tuf is a factor H and plasminogen binding protein.

Authors:  Anja Kunert; Josephine Losse; Christin Gruszin; Michael Hühn; Kerstin Kaendler; Stefan Mikkat; Daniela Volke; Ralf Hoffmann; T Sakari Jokiranta; Harald Seeberger; Ute Moellmann; Jens Hellwage; Peter F Zipfel
Journal:  J Immunol       Date:  2007-09-01       Impact factor: 5.422

9.  The N terminus of bacterial elongation factor Tu elicits innate immunity in Arabidopsis plants.

Authors:  Gernot Kunze; Cyril Zipfel; Silke Robatzek; Karsten Niehaus; Thomas Boller; Georg Felix
Journal:  Plant Cell       Date:  2004-11-17       Impact factor: 11.277

10.  Innate immunity against Francisella tularensis is dependent on the ASC/caspase-1 axis.

Authors:  Sanjeev Mariathasan; David S Weiss; Vishva M Dixit; Denise M Monack
Journal:  J Exp Med       Date:  2005-10-17       Impact factor: 14.307

View more
  5 in total

1.  Gallibacterium elongation factor-Tu possesses amyloid-like protein characteristics, participates in cell adhesion, and is present in biofilms.

Authors:  Jaqueline López-Ochoa; J Fernando Montes-García; Candelario Vázquez; Patricia Sánchez-Alonso; Victor M Pérez-Márquez; Patrick J Blackall; Sergio Vaca; Erasmo Negrete-Abascal
Journal:  J Microbiol       Date:  2017-09-02       Impact factor: 3.422

2.  Comparison of genomes of Brucella melitensis M28 and the B. melitensis M5-90 derivative vaccine strain highlights the translation elongation factor Tu gene tuf2 as an attenuation-related gene.

Authors:  Fangkun Wang; Zujian Qiao; Sen Hu; Wenxing Liu; Huajun Zheng; Sidang Liu; Xiaomin Zhao; Zhigao Bu
Journal:  Infect Immun       Date:  2013-05-28       Impact factor: 3.441

3.  Identification of proteins derived from Listeria monocytogenes inducing human dendritic cell maturation.

Authors:  Reza Mirzaei; Azad Saei; Fatemeh Torkashvand; Bahareh Azarian; Ahmad Jalili; Farshid Noorbakhsh; Behrouz Vaziri; Jamshid Hadjati
Journal:  Tumour Biol       Date:  2016-02-17

4.  Interaction of Leptospira elongation factor Tu with plasminogen and complement factor H: a metabolic leptospiral protein with moonlighting activities.

Authors:  Danielly G Wolff; Mónica M Castiblanco-Valencia; Cecília M Abe; Denize Monaris; Zenaide M Morais; Gisele O Souza; Sílvio A Vasconcellos; Lourdes Isaac; Patrícia A E Abreu; Angela S Barbosa
Journal:  PLoS One       Date:  2013-11-27       Impact factor: 3.240

5.  Efficacy of Resistance to Francisella Imparted by ITY/NRAMP/SLC11A1 Depends on Route of Infection.

Authors:  Daniel A Powell; Jeffrey A Frelinger
Journal:  Front Immunol       Date:  2017-03-15       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.